Annual CFI
$43.46 M
-$85.25 M-66.23%
31 December 2023
Summary:
Cara Therapeutics annual cash flow from investing activities is currently $43.46 million, with the most recent change of -$85.25 million (-66.23%) on 31 December 2023. During the last 3 years, it has risen by +$63.74 million (+314.36%). CARA annual CFI is now -66.23% below its all-time high of $128.71 million, reached on 31 December 2022.CARA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$2.50 M
-$12.79 M-83.65%
30 September 2024
Summary:
Cara Therapeutics quarterly cash flow from investing activities is currently $2.50 million, with the most recent change of -$12.79 million (-83.65%) on 30 September 2024. Over the past year, it has dropped by -$20.66 million (-89.20%). CARA quarterly CFI is now -96.29% below its all-time high of $67.38 million, reached on 30 June 2020.CARA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$13.54 M
-$20.66 M-60.41%
30 September 2024
Summary:
Cara Therapeutics TTM cash flow from investing activities is currently $13.54 million, with the most recent change of -$20.66 million (-60.41%) on 30 September 2024. Over the past year, it has dropped by -$104.55 million (-88.54%). CARA TTM CFI is now -91.47% below its all-time high of $158.62 million, reached on 30 September 2020.CARA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -66.2% | -89.2% | -88.5% |
| 3 y3 years | +314.4% | -82.7% | +111.7% |
| 5 y5 years | +152.5% | +102.6% | +113.1% |
CARA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -66.2% | +314.4% | -94.4% | +104.7% | -89.5% | +111.7% |
| 5 y | 5 years | -66.2% | +152.5% | -96.3% | +101.5% | -91.5% | +111.7% |
| alltime | all time | -66.2% | +147.4% | -96.3% | +101.5% | -91.5% | +111.7% |
Cara Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.50 M(-83.6%) | $13.54 M(-60.4%) |
| June 2024 | - | $15.29 M(-41.1%) | $34.19 M(-33.9%) |
| Mar 2024 | - | $25.95 M(-185.9%) | $51.70 M(+19.0%) |
| Dec 2023 | $43.46 M(-66.2%) | -$30.20 M(-230.4%) | $43.46 M(-63.2%) |
| Sept 2023 | - | $23.16 M(-29.4%) | $118.09 M(+1.7%) |
| June 2023 | - | $32.80 M(+85.2%) | $116.11 M(+2.8%) |
| Mar 2023 | - | $17.71 M(-60.1%) | $112.98 M(-12.2%) |
| Dec 2022 | $128.71 M(-2809.1%) | $44.42 M(+109.8%) | $128.71 M(+319.2%) |
| Sept 2022 | - | $21.18 M(-28.6%) | $30.70 M(+28.1%) |
| June 2022 | - | $29.68 M(-11.2%) | $23.96 M(+61.8%) |
| Mar 2022 | - | $33.43 M(-162.4%) | $14.81 M(-411.7%) |
| Dec 2021 | -$4.75 M(-76.6%) | -$53.58 M(-471.2%) | -$4.75 M(-95.9%) |
| Sept 2021 | - | $14.43 M(-29.7%) | -$115.33 M(+27.8%) |
| June 2021 | - | $20.53 M(+48.0%) | -$90.22 M(+108.0%) |
| Mar 2021 | - | $13.87 M(-108.4%) | -$43.37 M(+113.9%) |
| Dec 2020 | -$20.27 M(-33.6%) | -$164.16 M(-515.2%) | -$20.27 M(-112.8%) |
| Sept 2020 | - | $39.54 M(-41.3%) | $158.62 M(+614.6%) |
| June 2020 | - | $67.38 M(+82.3%) | $22.20 M(-211.2%) |
| Mar 2020 | - | $36.96 M(+150.8%) | -$19.96 M(-34.6%) |
| Dec 2019 | -$30.52 M(-63.2%) | $14.74 M(-115.2%) | -$30.52 M(-70.4%) |
| Sept 2019 | - | -$96.88 M(-484.0%) | -$103.08 M(>+9900.0%) |
| June 2019 | - | $25.23 M(-4.4%) | -$750.00 K(-99.0%) |
| Mar 2019 | - | $26.40 M(-145.6%) | -$77.11 M(-6.9%) |
| Dec 2018 | -$82.82 M | -$57.83 M(-1160.3%) | -$82.82 M(+391.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $5.45 M(-110.7%) | -$16.86 M(+64.7%) |
| June 2018 | - | -$51.14 M(-347.1%) | -$10.24 M(-66.4%) |
| Mar 2018 | - | $20.69 M(+154.7%) | -$30.51 M(-16.4%) |
| Dec 2017 | -$36.50 M(-181.1%) | $8.13 M(-32.7%) | -$36.50 M(+51.5%) |
| Sept 2017 | - | $12.08 M(-116.9%) | -$24.09 M(+12.7%) |
| June 2017 | - | -$71.40 M(-585.7%) | -$21.38 M(-137.4%) |
| Mar 2017 | - | $14.70 M(-28.4%) | $57.10 M(+26.8%) |
| Dec 2016 | $45.02 M(-149.1%) | $20.54 M(+39.0%) | $45.02 M(-167.0%) |
| Sept 2016 | - | $14.78 M(+108.7%) | -$67.19 M(-18.0%) |
| June 2016 | - | $7.08 M(+170.9%) | -$81.97 M(-8.0%) |
| Mar 2016 | - | $2.61 M(-102.9%) | -$89.06 M(-2.9%) |
| Dec 2015 | -$91.68 M(>+9900.0%) | -$91.66 M(>+9900.0%) | -$91.68 M(>+9900.0%) |
| Sept 2015 | - | -$1000.00(-83.3%) | -$28.00 K(-41.7%) |
| June 2015 | - | -$6000.00(0.0%) | -$48.00 K(0.0%) |
| Mar 2015 | - | -$6000.00(-60.0%) | -$48.00 K(+14.3%) |
| Dec 2014 | -$42.00 K(+740.0%) | -$15.00 K(-28.6%) | -$42.00 K(+50.0%) |
| Sept 2014 | - | -$21.00 K(+250.0%) | -$28.00 K(+154.5%) |
| June 2014 | - | -$6000.00(<-9900.0%) | -$11.00 K(+120.0%) |
| Mar 2014 | - | $0.00(-100.0%) | -$5000.00(0.0%) |
| Dec 2013 | -$5000.00(-101.0%) | -$1000.00(-75.0%) | -$5000.00(+25.0%) |
| Sept 2013 | - | -$4000.00(<-9900.0%) | -$4000.00(<-9900.0%) |
| June 2013 | - | $0.00 | $0.00 |
| Dec 2012 | $511.00 K(+1035.6%) | - | - |
| Dec 2011 | $45.00 K | - | - |
FAQ
- What is Cara Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Cara Therapeutics?
- What is Cara Therapeutics annual CFI year-on-year change?
- What is Cara Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cara Therapeutics?
- What is Cara Therapeutics quarterly CFI year-on-year change?
- What is Cara Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cara Therapeutics?
- What is Cara Therapeutics TTM CFI year-on-year change?
What is Cara Therapeutics annual cash flow from investing activities?
The current annual CFI of CARA is $43.46 M
What is the all time high annual CFI for Cara Therapeutics?
Cara Therapeutics all-time high annual cash flow from investing activities is $128.71 M
What is Cara Therapeutics annual CFI year-on-year change?
Over the past year, CARA annual cash flow from investing activities has changed by -$85.25 M (-66.23%)
What is Cara Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of CARA is $2.50 M
What is the all time high quarterly CFI for Cara Therapeutics?
Cara Therapeutics all-time high quarterly cash flow from investing activities is $67.38 M
What is Cara Therapeutics quarterly CFI year-on-year change?
Over the past year, CARA quarterly cash flow from investing activities has changed by -$20.66 M (-89.20%)
What is Cara Therapeutics TTM cash flow from investing activities?
The current TTM CFI of CARA is $13.54 M
What is the all time high TTM CFI for Cara Therapeutics?
Cara Therapeutics all-time high TTM cash flow from investing activities is $158.62 M
What is Cara Therapeutics TTM CFI year-on-year change?
Over the past year, CARA TTM cash flow from investing activities has changed by -$104.55 M (-88.54%)